Traditional analyses of PRR, involving measurements of the amount and size of DNA synthesised after exposure of cells to genotoxic agents, have indicated that replication of damaged templates does not lead to prolonged replication fork arrest, but causes an accumulation of daughter strand gaps in the genome[@R7]-[@R9]. Electron microscopy revealed gaps on both daughter strands in the vicinity of replication forks, suggesting re-priming downstream of lesions even on the leading strand[@R10]. In vertebrate cells, a partitioning of damage bypass into fork- and gap-associated events was reported[@R11]. These notions raise the question as to what extent DNA damage bypass is coupled to replication progression. In order to address theis issue, we designed a system that would allow us to activate the *RAD6* pathway at will by placing *RAD18*, encoding the ubiquitin ligase responsible for PCNA monoubiquitylation and a limiting factor for PRR[@R12], under control of inducible promoters ([Fig. S1](#SM){ref-type="supplementary-material"}). The *GAL1-10* promoter afforded overexpression of *RAD18* and enforced constitutive PCNA ubiquitylation ([Fig. S2a, b](#SM){ref-type="supplementary-material"}), whereas a truncated version[@R13] (*GALS-RAD18*) and a doxycycline-repressible construct[@R14] (*Tet-RAD18*) resulted in near wild-type (*WT*) protein levels, and PCNA modification required treatment with a DNA-damaging agent such as ultraviolet (UV) radiation ([Fig. S2a, c, d](#SM){ref-type="supplementary-material"}). All constructs conferred UV sensitivities comparable to *WT RAD18* when induced ([Fig. S3](#SM){ref-type="supplementary-material"}).

When synchronised uninduced *GAL-RAD18* cultures were treated with low UV doses at the G1/S boundary, cells passed through S phase and accumulated in G2/M with an activated checkpoint ([Fig. 1a, b](#F1){ref-type="fig"}, [S4](#SM){ref-type="supplementary-material"}). Induction of *RAD18* at this stage resulted in progression to the next G1 phase and deactivation of the checkpoint ([Fig. 1a, b](#F1){ref-type="fig"}). In order to determine whether this was due to productive damage bypass, we induced *RAD18* at various times during the cell cycle and compared survival ([Fig. 1c](#F1){ref-type="fig"}). Surprisingly, we found that the extent to which viability was restored was independent of the timing of *RAD18* expression ([Fig. 1d, h](#F1){ref-type="fig"}). Use of *GALS-RAD18* confirmed that the rescue was not due to forced overexpression of *RAD18* ([Fig. S5](#SM){ref-type="supplementary-material"}). In order to verify that the effect reflected the PRR pathway mediated by PCNA ubiquitylation, we repeated the experiment in a ubiquitylation-deficient PCNA mutant, *pol30(K164R)*​[@R2]. As expected, *RAD18* induction did not promote survival above uninduced controls ([Fig. 1e, h](#F1){ref-type="fig"}). In contrast, neither homologous recombination (HR, represented by *RAD52*) nor nucleotide excision repair (NER, represented by *RAD14*) was required for rescue of survival by *RAD18* ([Fig. 1f, g, h](#F1){ref-type="fig"}). Instead, viability in the absence of Rad18 was significantly reduced in both mutants, reflecting the synergistic relationship between PRR and HR or NER, respectively. Hence, ubiquitin-mediated DNA damage bypass can effectively be delayed without adverse effects on viability until after the bulk of genome replication is completed.

These observations, together with the notion that expression of *REV1*, encoding one of the damage-tolerant polymerases, peaks in G2/M[@R15], raised the possibility that PRR is naturally delayed until after S phase. However, when G1-synchronised *WT* cells were irradiated and released, PCNA ubiquitylation was maximal in S phase, suggesting that damage bypass is at least initiated during replication ([Fig. 2a, b](#F2){ref-type="fig"}). Moreover, whilst *WT* cells only showed a transient checkpoint signal around G2/M, PRR defects resulted in strong checkpoint activation early during S phase ([Fig. 2c, d](#F2){ref-type="fig"}), indicating that the *RAD6* pathway normally contributes to damage processing, thereby effectively preventing checkpoint signalling during replication.

Ubiquitylation of PCNA requires the clamp to reside on DNA[@R12],[@R16],[@R17]. Hence, damage to G2-arrested cells does not normally result in modification[@R12]. However, when *GALS-RAD18* cells were irradiated in G1 and allowed to complete the cell cycle in the absence of Rad18, induction of PRR in G2/M resulted in PCNA ubiquitylation ([Fig. 2e](#F2){ref-type="fig"}). Consistent with the modification, fractionation of cell extracts revealed a prolonged association of PCNA in G2/M with chromatin in response to DNA damage inflicted at the beginning of S phase ([Figs. 2f-h](#F2){ref-type="fig"}). The association pattern was unchanged in *rad18Δ*, indicating that ubiquitylation is not responsible for the localisation pattern of PCNA ([Fig. S6](#SM){ref-type="supplementary-material"}). Dissociation of the replication factor Mcm2 over the course of the cell cycle suggested that the chromatin-bound PCNA was not engaged at active replication forks at the late time points ([Figs. 2f-h](#F2){ref-type="fig"}, [S6](#SM){ref-type="supplementary-material"}). We interpret this finding to indicate that DNA damage left unrepaired during S phase causes some PCNA to remain associated with daughter-strand gaps even after bulk DNA synthesis is completed, and that this residual pool of PCNA is the target for ubiquitylation in G2/M. Alternatively, PCNA may have been reloaded and subsequently ubiquitylated at PRR sites.

Having established that ubiquitin-dependent PRR can rescue cell viability irrespective of its timing, we wished to determine which of its two branches, TLS or error-free damage avoidance, was mainly responsible for survival during and after S phase, respectively. We therefore analysed viability of *Tet-RAD18* cells deficient in all three damage-tolerant polymerases (*rev1Δ rev3Δ rad30Δ*, designated as *tlsΔ*) and/or *UBC13* ([Fig. 3a](#F3){ref-type="fig"}). Whereas the former strain should be devoid of TLS activity, deletion of *UBC13* should selectively prevent PCNA polyubiquitylation and thereby error-free damage avoidance[@R2], and combination of the mutations should completely abolish PRR. Lack of *UBC13* had no measurable effect on survival during S phase or in G2/M, whereas viability was drastically reduced in *tlsΔ*, suggesting that throughout the cell cycle TLS is much more important for tolerance to UV lesions than error-free bypass ([Fig. 3b, d](#F3){ref-type="fig"}). Examination of individual polymerase mutants revealed major contributions of Rev1 and polymerase ζ, encoded by *REV3* ([Fig. 3c, d](#F3){ref-type="fig"}). Further sensitisation in *tlsΔ ubc13Δ* beyond the level of *tlsΔ* indicated that polyubiquitin-dependent PRR might still play a role in a backup function ([Fig. 3b](#F3){ref-type="fig"}, [S7](#SM){ref-type="supplementary-material"}). Hence, both TLS and error-free PRR appear capable of acting during S phase and in a postreplicative manner.

The notion that PRR can effectively be uncoupled from genome replication allowed us to visualise and quantify bypass-dependent DNA synthesis by means of 5-bromodeoxyuridine (BrdU) labelling[@R18]. In order to observe PRR-associated DNA synthesis, we irradiated uninduced *Tet-RAD18* cells in G1, allowed passage through S phase and induced *RAD18* in the presence of BrdU when cells had reached the G2/M arrest ([Fig. 4a](#F4){ref-type="fig"}). Nocodazole was used to prevent DNA synthesis due to entry into the next cell cycle. Analysis of a control strain, *rad18Δ*, revealed virtually no BrdU incorporation ([Fig. 4b](#F4){ref-type="fig"}), while induction of *RAD18* resulted in de novo DNA synthesis as judged by the appearance of a BrdU signal. Inactivation of TLS caused a much stronger reduction in BrdU incorporation than deletion of *UBC13*, and no signal above the background was observed in *tlsΔ ubc13Δ* ([Fig. 4b, c](#F4){ref-type="fig"}). These results are consistent with the effects of TLS and Ubc13 on survival, again indicating that TLS accounts for the majority of PRR. Quantification of the signals also showed that among the three single polymerase mutants, only *rev3Δ* resulted in an appreciable PRR defect, suggesting significant redundancy among the polymerases, but a dominant role of polymerase ζ in postreplicative processing of UV lesions ([Fig. 4d, e](#F4){ref-type="fig"}). The discrepancy between the survival defect of *rev1Δ* and its ability to incorporate BrdU is surprising, but it might indicate ubiquitin-independent contributions of this polymerase to damage processing, which would affect overall damage sensitivity but would not be detectable by *RAD18* induction. Consistent with this model, a *rad18Δ tlsΔ* mutant is more UV-sensitive than *rad18Δ* alone[@R19], and similar findings have been reported for vertebrate cells[@R11].

The distribution of PRR tracts along chromosomal DNA was revealed by DNA fibre analysis. As a control, we visualised replication tracts in hydroxyurea (HU)-treated cells, detectable as strongly and continuously labelled regions mostly originating from bidirectional replication forks ([Fig. 4f](#F4){ref-type="fig"}). Fibres observed after postreplicative labelling of irradiated *Tet-RAD18* cells ([Fig. 4a](#F4){ref-type="fig"}) looked strikingly different: DNA synthesis had occurred in numerous small patches dispersed along the chromosomes ([Fig. 4g](#F4){ref-type="fig"}). Their almost complete absence in *rad18Δ* and in uninduced cells confirmed that they represented PRR and not replication tracts ([Fig. S8a-c](#SM){ref-type="supplementary-material"}). Taking into account an average inter-origin distance of 40 to 100 kb[@R20], the density of the patches also suggests that many of them do not originate from stalled forks. Whereas deletion of *UBC13* had no notable effect on their distribution, inactivation of TLS caused some reduction in their density, and signals in the *tlsΔ ubc13Δ* mutant were again reduced to background ([Fig. 4h](#F4){ref-type="fig"}, [S8d](#SM){ref-type="supplementary-material"}). After irradiation with 10 and 20 J/m^2^, their density roughly correlated with the UV dose ([Fig. 4i](#F4){ref-type="fig"}). Notably, at 40 J/m^2^ ([Fig. S9a](#SM){ref-type="supplementary-material"}), the pattern became reminiscent of HU-stalled replication forks. At the same time, flow cytometry indicated that cells had not completed S phase by the time of *RAD18* induction ([Fig. S9b](#SM){ref-type="supplementary-material"}). Hence, it appeared that high UV doses might have impeded progression of replication forks to such an extent that replicative DNA synthesis and PRR could no longer be separated.

The finding that even low damage levels cause a G2/M checkpoint arrest in *RAD18*-deficient cells highlights the importance of PRR for completion of the cell cycle[@R21]. Based on previous measurements[@R22],[@R23] a UV dose of 20 J/m^2^ introduces approximately 0.3-0.5 cyclobutane pyrimidine dimers (CPDs)/kb into the budding yeast genome. The tract density determined by us therefore suggests that cells can process a significant fraction of all UV-induced lesions by PRR in G2/M. Although our data suggest that PRR is normally active during S phase, they show that damage tolerance is fully functional even when uncoupled from genome replication. A pronounced peak of *REV1* expression during G2/M suggests that this mode of PRR may be biologically relevant[@R15]. The predominance of TLS over the error-free pathway is surprising and contrasts with previous reports based on the replication of plasmids containing a defined 6-4 photoproduct[@R6] or exposure to chronic low-dose UV[@R21]. However, the balance between TLS and error-free bypass may depend as much on the nature of the lesion (mainly CPDs in our case) as on the overall amount of damage. Likewise, the dramatic UV sensitivity of TLS-deficient strains is unexpected, but may be explained by our use of synchronised cell populations exposed to damage immediately before the onset of replication. In this situation, alternative repair pathways might not be readily available before lesions are encountered by replication forks. Finally, although a prominent role of polymerase η might have been predicted based on its biochemical properties[@R24], our analysis indicates some redundancy among the TLS polymerases. The unique importance of polymerase ζ could be connected to its role as an "extender polymerase" that cooperates with other TLS polymerases and can therefore not be replaced[@R25]-[@R27]. In contrast to traditional PRR assays that largely rely on unsynchronised cultures of extremely damage-sensitive, NER-deficient cells and do not address the relevance of the observed activity for survival[@R7],[@R9], our approach has permitted the visualisation of productive PRR in synchronised populations. Further characterisation of this experimental system should give insight into the structure of PRR tracts and the yet elusive mechanism of the error-free pathway of lesion bypass.

Methods Summary {#S1}
===============

Yeast strains {#S2}
-------------

All experiments were performed in isogenic strains, listed in [Table S1](#SM){ref-type="supplementary-material"}. Details about their construction are given in the additional Methods section.

Determination of cell survival and checkpoint activation {#S3}
--------------------------------------------------------

*GAL-RAD18* cells were synchronised in G1, irradiated (254 nm) and released into S phase in lactate medium. At the indicated time points, *RAD18* expression was induced for 2 h by addition of galactose. Survival relative to unirradiated cultures was determined by colony counting on glucose medium. *Tet-RAD18* cells were synchronised, irradiated, and released in the presence of doxycycline. At the indicated times cells were plated directly onto medium with or without doxycycline for colony counting. Checkpoint activation was monitored by observing Rad53 phosphorylation in total cell extracts.

Detection of PCNA ubiquitylation {#S4}
--------------------------------

^His^PCNA was isolated from *^His^POL30* strains under denaturing conditions, and ubiquitylated forms were detected by Western blot as previously described[@R2],[@R4],[@R28].

Chromatin binding assays {#S5}
------------------------

Fractionation of total cell extracts prepared by spheroplast lysis was achieved by centrifugation through a sucrose cushion essentially as described[@R29].

Detection of BrdU-labelled DNA {#S6}
------------------------------

Briefly, total DNA from cells grown in the presence of 0.4 mg/ml BrdU for 3 h, isolated by glass bead disruption and phenol/chloroform extraction, was denatured at 95°C, snap-cooled on ice and spotted onto nylon membrane. After UV-crosslinking the membrane was probed with an anti-BrdU antibody, followed by chemiluminescence detection. A detailed description is given in the additional Methods section.

DNA fibre spreading {#S7}
-------------------

Analysis of DNA fibres after spheroplast lysis of cells labelled for 3 h (or 90 min in case of HU-treated cells) with 0.4 mg/ml BrdU was performed essentially as described[@R30]. A full protocol is given in the additional Methods section.

Methods {#S8}
=======

Yeast strains and plasmids {#S9}
--------------------------

The *GAL-RAD18* strains were based on *rad18Δ* cells carrying *RAD18* under control of the *GAL1-10* promoter on an integrative plasmid. *GALS-RAD18* was constructed by replacement of the *RAD18* promoter in the endogenous locus with a truncated version of the *GAL1* promoter (marked by *KanMX*)[@R13]. *Tet-RAD18* was constructed by replacement of the *RAD18* promoter with a TetO~7~ array (marked by *KanMX*) and integration of a construct encoding a TetR′-Ssn6 fusion[@R14], rendering *RAD18* repressible by doxycyline. For the purpose of BrdU incorporation, genes encoding exogenous thymidine kinase and a nucleoside transporter were introduced on an integrative plasmid, p306-BrdU-Inc[@R18]. Features were combined by subsequent transformations or by mating and tetrad dissection. All strains were grown at 30°C.

Determination of cell survival and checkpoint activation {#S10}
--------------------------------------------------------

*GAL-RAD18* cells were pregrown in 2% lactate medium (pH 5.5) to exponential phase and synchronised in G1 with 10 μg/ml α-factor for 2.5 h. Cells were washed and resuspended in water, UV-irradiated at 254 nm and released into lactate medium. Incubation was continued in the dark to prevent photoreactivation. At the indicated time points, galactose (2%) or water was added. After further incubation for 2 h, cells were plated onto glucose (YPD) medium, and survival relative to unirradiated cultures was determined by colony counting after 3 days. *Tet-RAD18* cells were pregrown in YPD containing 2 μg/ml doxycycline, synchronised and irradiated as above, and released into YPD with doxycycline to maintain *RAD18* repression. At the indicated times cells were plated directly onto YPD with or without doxycycline for colony counting. Checkpoint activation was monitored by observing Rad53 phosphorylation with an anti-Rad53 antibody on Western blots of total cell extracts.

Detection of BrdU-labelled DNA {#S11}
------------------------------

After BrdU labelling of the appropriate strains according to the relevant scheme (usually 3 h), total DNA isolated from ca. 5·10^7^ cells was resuspended in Tris-EDTA (TE) buffer, and the concentration was adjusted to 500 ng/μl. After heat-denaturation and snap-cooling, aliquots of 1 μg were spotted onto Hybond N+ nylon membrane (GE Healthcare) and subjected to UV crosslinking in a Stratalinker™ (Stratagene) at 1.2·10^5^ μJ. Subsequently, the membrane was equilibrated in phosphate-buffered saline (PBS) containing 0.1% Tween-20 (PBST), blocked with 5% non-fat milk in PBST for 30 min and probed with a monoclonal anti-BrdU antibody (B44, Becton-Dickinson, at 0.025 μg/ml) in PBST + 0.5% milk overnight. After washing and addition of secondary antibody (anti-mouse HRP conjugate in PBST + 0.5% milk), the blot was developed using enhanced chemiluminescence (GE Healthcare) and exposed to Hyperfilm™. In parallel, the signals were directly quantified using a Fuji LAS3000 imager. At least three independent experiments were performed to assure reproducibility. From a representative set, DNA samples were spotted a minimum of three times and developed together to achieve comparability and determine averages and standard deviations. Values were plotted relative to the average signal of all uninduced cultures, which was set to 1. Hence, the numbers are comparable only within each experiment.

DNA fibre spreading {#S12}
-------------------

For labelling of replication tracts, cells were treated with 200 mM HU for 90 min. For PRR tract labelling, cells were treated as described above for the quantification of BrdU signals. After the desired treatment, a culture of ca. 0.5·10^7^ BrdU-labelled cells was treated with 0.1% sodium azide. Cells were harvested and incubated with 0.2 mg/ml Zymolyase-100T (Seikagaku) in 1 ml of 50 mM potassium phosphate, pH 7.5, 0.6 M sorbitol and 10 mM dithiothreitol for 1 h at 35°C. Cells were pelleted and resuspended in 200 μl of PBS. DNA was spread onto microscope slides by allowing a drop of the solution to run down a tilted slide as described [@R30]. The dried slides were blocked with PBST + 2% bovine serum albumin (BSA) for 30 min. Rat anti-BrdU antibody (BU1/75, AbD Serotech, at 5 μg/ml) in PBST + 0.2% BSA was added for 3 h, and donkey anti-rat IgG coupled to Alexa 594 (Molecular Probes, at 5 μg/ml) was used for immunostaining (30 min). Total DNA was stained with YOYO-1 (Molecular Probes, at 1.3 μM) for 30 min, slides were washed with PBST + 0.2% BSA and covered with anti-fade reagent ProLong® Gold (Invitrogen). Fluorescence microscopy was performed with a 63x objective on an Axio Imager (ZEISS) equipped with a Hamamatsu CCD Camera. For quantification, a length of 1 μm was assumed to represent 2.59 kb of DNA[@R30], and densities of PRR tracts were estimated with the Volocity software (Improvision) by determining average BrdU spot densities on isolated DNA fibres spanning lengths from 10 to 130 kbp. Total numbers of analysed fibres were as follows: *Tet-RAD18* (10 J/m^2^) -- 68; *Tet-RAD18* (20 J/m^2^) -- 117; *Tet-RAD18 ΔTLS* -- 36; *Tet-RAD18 ubc13Δ* -- 33; *Tet-RAD18 ΔTLS ubc13Δ* -- 13; *rad18Δ* -- 17. The values were used for determination of the density distribution ([Fig. 4h](#F4){ref-type="fig"}) and the median tract densities ([Fig. 4i](#F4){ref-type="fig"}).
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![Ubiquitin-dependent DNA damage bypass can be delayed until after genome replication\
**a** Cell cycle profiles of synchronised *GAL-RAD18* cultures either unirradiated (left) or treated with 10 J/m^2^ UV (middle, right). *RAD18* expression was induced by galactose (Gal, right). **b** Time course of Rad53 phosphorylation in *rad18Δ* and *GAL-RAD18,* treated as above. **c** Experimental scheme for *GAL-RAD18* induction during and after S phase. αF: alpha factor. **d-g** Survival of the indicated *GAL-RAD18* strains (UV dose: 10 J/m^2^ -- *rad14Δ*: 2 J/m^2^). Error bars represent standard deviations from 3 experiments. **d**​ *POL30*; **e**​ *pol30(K164R)*; **f**​ *rad52Δ*; **g**​ *rad14Δ*. **h** Cell cycle profiles at the time of *RAD18* induction.](ukmss-29881-f0001){#F1}

![PRR normally operates during S phase, but chromatin-bound PCNA can be ubiquitylated in G2/M\
**a** Ubiquitylation of ^His^PCNA in *WT* cells after release from G1 arrest (UV dose: 20 J/m^2^). **b** Cell cycle profile of the above culture. **c** Time course of Rad53 phosphorylation in *WT* and *rad18Δ* cells treated as above. **d** Cell cycle profiles of the above cultures. **e**​ ^His^PCNA ubiquitylation in *GALS-RAD18* cells treated as described in [Fig. 1c](#F1){ref-type="fig"}. **f** Distribution of PCNA and Mcm2 in whole-cell extracts (W), soluble (S) and chromatin-associated (C) fractions prepared from G1-irradiated cultures (± 20 J/m^2^) at the indicated times after release. Pgk1 and Orc6 served as controls for soluble and chromatin-bound proteins, respectively. **g** Quantification of PCNA and Mcm2 in the chromatin fractions. **h** Cell cycle profiles of the above cultures. Since irradiation slows down cell cycle progression, different time scales were used for damaged versus undamaged cells in panels f-h in order to relate comparable cell cycle stages to each other.](ukmss-29881-f0002){#F2}

![UV-induced lesions are bypassed predominantly by TLS\
**a** Experimental scheme for *Tet-RAD18* induction during and after S phase (UV dose: 10 J/m^2^). **b, c** Survival of the indicated strains, relative to unirradiated controls. Standard deviations were derived from 4 experiments. **d** Cell cycle profiles of the indicated strains at the time of plating.](ukmss-29881-f0003){#F3}

![Quantification and visualisation of PRR tracts in G2/M-arrested cells\
**a** Experimental scheme for labelling of PRR tracts in *Tet-RAD18* cells (UV dose: 20 J/m^2^). **b** Dot blot for detection of BrdU incorporation. **c** Quantification of BrdU signals with s.d. from a minimum of 3 independent experiments. **d** Dot blot for detection of BrdU incorporation in single TLS polymerase mutants. **e** Quantification of the above signals. **f** Fluorescence microscopy images of DNA fibres (green) labelled with BrdU (red) in HU-treated S phase cells. **g** Fluorescence microscopy images of DNA fibres labelled postreplicatively with BrdU in *Tet-RAD18* cells. **h** Density distribution of BrdU patches. **i** Dose dependence of BrdU patch densities. Horizontal bars indicate median values.](ukmss-29881-f0004){#F4}
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